News

– Interim results show sustained reduction in hereditary angioedema attacks and no new safety signals in patients treated for one year CARLSBAD, Calif., Nov. 13, 2022 /PRNewswire/ — Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today presented […]

SAN DIEGO, Nov. 11, 2022 /PRNewswire/ — Kintara Therapeutics, Inc. (Nasdaq: KTRA) (“Kintara” or the “Company”), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced that it will effect […]

PENNINGTON, N.J. and SAN DIEGO, Nov. 11, 2022 /PRNewswire/ — OncoSec Medical Incorporated (NASDAQ: ONCS) (the “Company” or “OncoSec”), a clinical-stage biotechnology company developing intratumoral immunotherapies that stimulate the patient’s immune system to target cancer […]

DuraCAR Drug Addresses Major Need in Solid Tumor Therapies SAN DIEGO, Nov. 10, 2022 /PRNewswire/ — Regen BioPharma, Inc. (OTC PINK: RGBP) and (OTC PINK: RGBPP)has recently discussed the use of CAR-T therapies in cancer […]

CARLSBAD, Calif., Nov. 10, 2022 /PRNewswire/ — Tyra Biosciences, Inc. (Nasdaq: TYRA), a precision oncology company focused on developing purpose-built therapies to overcome tumor resistance and improve outcomes for patients with cancer, today announced that […]

SAN DIEGO–(BUSINESS WIRE)—- $JANX–Janux Therapeutics Reports Third Quarter 2022 Financial Results and Business Highlights Click here to view original post

Two investment groups have come together to purchase the CDMO Alcami. Global Healthcare Opportunities, otherwise known as GHO Capital, and The Vistra Group joined to acquire a controlling interest in the Alcami Corporation from funds […]

Company prepares for commercialization, continued ExoVerita™ platform development and funding SAN DIEGO, Nov. 10, 2022 /PRNewswire/ — Biological Dynamics, an exosome isolation technology and early disease detection company, today announced new executive appointments to fuel […]

SAN DIEGO–(BUSINESS WIRE)– #SITC2022–Artiva Biotherapeutics Presents Preclinical Data for AB-101, an Optimized Allogeneic NK Cell Therapy Candidate, at SITC 2022 Annual Meeting Click here to view original post

ST. LOUIS & SAN DIEGO–(BUSINESS WIRE)–Wugen, Inc., a clinical-stage biotechnology company developing a pipeline of allogeneic cell therapies to treat a broad range of hematological and solid tumor malignancies, today announced that management will present […]

Affordable, On Demand Access to High-Quality Long Reads on a Benchtop Sequencer SAN DIEGO, Nov. 10, 2022 /PRNewswire/ — Element Biosciences, Inc.— developer of an innovative DNA sequencing platform disrupting the genomics industry — today […]

EVANSTON, Ill.–(BUSINESS WIRE)–Aptinyx Inc. (NASDAQ:APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, today announced upcoming poster presentations at the 52nd Annual Meeting of the Society for […]

SAN DIEGO — Rayyan Gorashi is keeping her options open. After all, she’s still a second-year bioengineering Ph.D. student at UC San Diego, and there are so many careers to explore. Patent law has been […]

CARLSBAD, Calif., Nov. 9, 2022 /PRNewswire/ — Natural Alternatives International, Inc. (“NAI”) (Nasdaq: NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, today announced net income of $1.1 million, or $0.18 per diluted […]

SAN DIEGO, Nov. 9, 2022 /PRNewswire/ — Kintara Therapeutics, Inc. (Nasdaq: KTRA) (“Kintara” or the “Company”), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced financial results for its […]

Former Partner | SVP Development, Jake Rohe, transitions to Managing Partner | President in the latest evolution of PMB’s leadership. SAN DIEGO, Nov. 9, 2022 /PRNewswire/ — PMB, a leading, purpose-driven healthcare real estate developer […]

SAN DIEGO, Nov. 9, 2022 /PRNewswire/ — Halozyme Therapeutics, Inc. (NASDAQ: HALO) (“Halozyme”) today announced that members of its management team are scheduled to present and host investor meetings at the following investor conferences: Event: […]

NEW YORK–(BUSINESS WIRE)– #CheckYourFoodTube–Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Lucid”, the “Company”), a commercial-stage, cancer prevention medical diagnostics company, and majority-owned subsidiary of PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (“PAVmed”), today announced the commencement of production of […]

Advanced key priorities: initiated manufacturing infrastructure project to support growth Increased 2022 cash and investments guidance CARLSBAD, Calif., Nov. 9, 2022 /PRNewswire/ — Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) (the “Company”) today reported financial results for […]

SAN DIEGO, Nov. 8, 2022 /PRNewswire/ — Viking Therapeutics, Inc. (“Viking”) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced that its chief executive […]

Company has three distinct rare disease programs in clinical development – myotonic dystrophy type 1 (DM1), facioscapulohumeral muscular dystrophy (FSHD), and Duchenne muscular dystrophy (DMD) On track for preliminary assessment of AOC 1001 MARINA™ trial […]

– APONVIE™ approval by FDA, U.S. launch planned for Q1 2023 – – ZYNRELEF® unit demand grew 18% over prior quarter in Q3 2022 – – Oncology Care Franchise net product sales grew 13% over […]

SAN DIEGO, Nov. 8, 2022 /PRNewswire/ — CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD) products, today announced that it will release […]

SAN DIEGO, Nov. 8, 2022 /PRNewswire/ — Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today reported financial results for the third quarter of 2022 and recent corporate updates. “In the third quarter, […]

SAN DIEGO–(BUSINESS WIRE)–Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will participate at the following upcoming investor conferences: Guggenheim 4th Annual Immunology and Neurology Day November 14, 2022 in New York, NY J.P. Morgan […]

SAN DIEGO, Nov. 8, 2022 /PRNewswire/ — Leica Biosystems, a technology leader in automated staining and brightfield and fluorescent imaging, has acquired Cell IDx, Inc., a leader in multiplexed tissue profiling. Founded in 2012 and […]

PENNINGTON, N.J. and SAN DIEGO, Nov. 8, 2022 /PRNewswire/ — OncoSec Medical Incorporated (NASDAQ: ONCS) (the “Company” or “OncoSec”), a clinical-stage biotechnology company focused on developing intratumoral immunotherapies to stimulate the patient’s own immune system […]

SAN DIEGO, Calif. and CALIFORNIA, Md., Nov. 8, 2022 /PRNewswire/ — Sentynl Therapeutics, Inc. (“Sentynl”) a US-based biopharmaceutical company focused on bringing innovative therapies to patients living with rare disease, joins the global Menkes disease […]